Magazine Article | November 1, 2022

Pioneering In-House, Continuous Manufacturing

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader
Follow Me On Twitter @WayneKoberstein

Being a layperson in bioproduction, I wanted to know more about the concept and reality of continuous manufacturing (CM), and especially why a company would elect to build its own CM capability in-house. A natural candidate for educating me is an advocate for companies using CM in whatever setting fit their needs. She is Patricia (Trish) Hurter, a pharma manufacturing veteran and now CEO of Lyndra Therapeutics.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader